Molecular mechanism for the selective impairment of cancer mitochondrial function by a mitochondrially targeted vitamin E analogue.

MLA

Rodríguez-Enríquez, Sara, et al. “Molecular Mechanism for the Selective Impairment of Cancer Mitochondrial Function by a Mitochondrially Targeted Vitamin E Analogue.” Biochimica et Biophysica Acta, vol. 1817, no. 9, Sept. 2012, pp. 1597–607. EBSCOhost, https://doi.org/10.1016/j.bbabio.2012.05.005.

APA

Rodríguez-Enríquez, S., Hernández-Esquivel, L., Marín-Hernández, A., Dong, L.-F., Akporiaye, E. T., Neuzil, J., Ralph, S. J., & Moreno-Sánchez, R. (2012). Molecular mechanism for the selective impairment of cancer mitochondrial function by a mitochondrially targeted vitamin E analogue. Biochimica et Biophysica Acta, 1817(9), 1597–1607. https://doi.org/10.1016/j.bbabio.2012.05.005

Chicago

Rodríguez-Enríquez, Sara, Luz Hernández-Esquivel, Alvaro Marín-Hernández, Lan-Feng Dong, Emmanuel T Akporiaye, Jiri Neuzil, Stephen J Ralph, and Rafael Moreno-Sánchez. 2012. “Molecular Mechanism for the Selective Impairment of Cancer Mitochondrial Function by a Mitochondrially Targeted Vitamin E Analogue.” Biochimica et Biophysica Acta 1817 (9): 1597–1607. doi:10.1016/j.bbabio.2012.05.005.